insights_auto
Why is KLBF down 2.96%?
Dive Deeperchevron_right
KLBF:IDX
Kalbe Farma Tbk PT
IDR 655.00
arrow_downward
-2.96%(-20.00) 1D
Oct 19, 4:13:34 PM GMT+7 · IDR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for KLBF...
Open
IDR 640
High
IDR 670
Low
IDR 630
Mkt. cap
30.66T
Avg. vol.
66.29M
Volume
174.70M
Dividend
3.05%
Quarterly dividend
IDR 5
Ex-dividend date
Jun 4, 2026
P/E ratio
8.23
52-wk high
IDR 1,345
52-wk low
IDR 630
EPS
IDR 80
Shares outstanding
46.81B
No. of employees
13K
Open
IDR 640
High
IDR 670
Low
IDR 630
Mkt. cap
30.66T
Avg. vol.
66.29M
Volume
174.70M
Dividend
3.05%
Quarterly dividend
IDR 5
Ex-dividend date
Jun 4, 2026
P/E ratio
8.23
52-wk high
IDR 1,345
52-wk low
IDR 630
EPS
IDR 80
Shares outstanding
46.81B
No. of employees
13K
News stories
From web sources and news partners
The Korea Times
·
1 hour ago
Nasdaq climbs over 1% as AI-linked stocks recover ahead of key earnings
www.marketscreener.com
·
40 minutes ago
FactSet Research : Are “Magnificent 7” Companies Still Top Contributors to S&P 500 Earnings Growth for Q3
Benzinga
·
12 minutes ago
Dow Analyst No Longer Bearish As Earnings Stability Improves
TradingView
·
3 hours ago
The Dow Jones Index Opens 0.08% Lower
Profile
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, with a distribution arm that reaches over one million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
About Kalbe Farma Tbk PT